Author

Tessie B McNeely

Observed names: McNeely, Tessie B., T B McNeely, T MCNEELY, T. B. McNeely, T. McNeely, T.B. McNeely, TB McNeely, Tessie B. McNeely, Tessie B. Mcneely, Tessie McNeely, Tessie Mcneely

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: University of North Carolina at Chapel Hill, Merck & Co., Inc., Rahway, NJ, USA (United States), National Institutes of Health, Amgen (United States), United States Department of Veterans Affairs, University of Kentucky, Lexington VA Health Care System, Yale University, National Institute of Dental and Craniofacial Research, Duke Medical Center, Albany Medical College

OpenAlex ID: A5108564365

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

1995 · T B McNeely, M Dealy, et al. · Journal of Clinical Investigation · 436

PDF

Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery

2013 · Vance G. Fowler, Keith B. Allen, et al. · JAMA · 373

A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

2006 · Nelly A. Kuklin, Desmond J. Clark, et al. · Infection and Immunity · 263

Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Secretory Leukocyte Protease Inhibitor Occurs Prior to Viral Reverse Transcription

1997 · Tessie B. McNeely, Diane C. Shugars, et al. · Blood · 253

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

1997 · Y Zhang, D L DeWitt, et al. · Journal of Clinical Investigation · 185

PDF

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1

1997 · SM Wahl, TB McNeely, et al. · Oral Diseases · 156

Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.

1990 · T B McNeely, S J Turco · The Journal of Immunology · 143

Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania

1989 · T B McNeely, G Rosen, et al. · Biochemical Journal · 129

PDF

Titrating T‐Cell Epitopes within Self‐Assembled Vaccines Optimizes CD4+ Helper T Cell and Antibody Outputs

2014 · Rebecca R. Pompano, Jianjun Chen, et al. · Advanced Healthcare Materials · 125

Comparison of the Opsonic Activity of Human Surfactant Protein A for Staphylococcus aureus and Streptococcus pneumoniae with Rabbit and Human Macrophages

1993 · T. B. McNeely, J. D. Coonrod · The Journal of Infectious Diseases · 119

Aggregation and Opsonization of Type a but not Type B Hemophilus Influenzae by Surfactant Protein A

1994 · T B McNeely, J D Coonrod · American Journal of Respiratory Cell and Molecular Biology · 114

Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

2012 · Amita Joshi, Greg Pancari, et al. · Human Vaccines & Immunotherapeutics · 113

PDF

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus

2003 · Joseph G Joyce, Chitrananda Abeygunawardana, et al. · Carbohydrate Research · 105

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors

2014 · Tessie B McNeely, Najaf A Shah, et al. · Human Vaccines & Immunotherapeutics · 98

PDF

Inhibition of protein kinase C activity by the Leishmaniadonovani lipophosphoglycan

1987 · Tessie B. McNeely, Salvatore J. Turco · Biochemical and Biophysical Research Communications · 94

Stable DNA transfection of a wide range of trypanosomatids

1991 · Cara M. Coburn, Karen M. Otteman, et al. · Molecular and Biochemical Parasitology · 75

Antibody Responses to Capsular Polysaccharide Backbone and O-Acetate Side Groups of Streptococcus pneumoniae Type 9V in Humans and Rhesus Macaques

1998 · Tessie B. McNeely, Joan M. Staub, et al. · Infection and Immunity · 56

PDF

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo

2010 · Tim Ebert, Sharon Smith, et al. · Human Antibodies · 50

Selection and Characterization of Murine Monoclonal Antibodies toStaphylococcus aureusIron-Regulated Surface Determinant B with Functional Activity In Vitro and In Vivo

2009 · Martha Brown, Rose Kowalski, et al. · Clinical and Vaccine Immunology · 44

Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

1997 · S M Wahl, P Worley, et al. · PubMed · 39

Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies

1990 · Tessie B. McNeely, Douglas L. Tolson, et al. · Glycobiology · 38

The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation

1985 · TB McNeely, MJ Griffith · Blood · 35

PDF

Naturally occurring IgG antibody levels to theStaphylococcus aureusprotein IsdB in humans

2013 · Julie K Zorman, Mark Esser, et al. · Human Vaccines & Immunotherapeutics · 28

PDF

Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB)

2012 · Gregory Pancari, Hongxia Fan, et al. · Frontiers in Cellular and Infection Microbiology · 25

PDF

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection

2005 · R HEPLER, R KELLY, et al. · Vaccine · 24

Works count: 49

Citation count: 3,226

H-index: 24

I10-index: 30